Defying Dementia: Preliminary studies into peptide-based inhibitors of Tau aggregation - Research Portal | Lancaster University

Home > Research > Projects > Defying Dementia: Preliminary studies into pept...

View graph of relations

Defying Dementia: Preliminary studies into peptide-based inhibitors of Tau aggregation

Project: Research

Status	Finished
Effective start/end date	1/07/18 → 31/12/18

Funding

Lancaster University: £38,647.47

Allsop, David (Principal Investigator)
Fullwood, Nigel (Co-Investigator)

Research outputs

Liposome delivery systems for the treatment of Alzheimer’s disease
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Untangled - peptide-based inhibitors of tau aggregation as a potential treatment for Alzheimer's disease
Research output: Contribution to Journal/Magazine › Meeting abstract
Oxidative Stress, Cytotoxic and Inflammatory Effects of Urban Ultrafine Road-Deposited Dust from the UK and Mexico in Human Epithelial Lung (Calu-3) Cells
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Liposome nanoparticle conjugation and cell penetrating peptide sequences ( CPPs ) enhance the cellular delivery of the tau aggregation inhibitor RI ‐ AG03
Research output: Contribution to Journal/Magazine › Journal article › peer-review